Foundayo is the brand name for orforglipron, a new once-a-day weight loss tablet made by Eli Lilly, the same company behind Mounjaro.
It was authorised for use in the UK by the MHRA on 10 August 2026, and became available by private prescription later that month.
Unlike Mounjaro and Wegovy, it's a pill, not an injection.
Unlike the semaglutide tablet some people have heard of, you don't need to take it on an empty stomach or wait before eating.
In the ATTAIN-1 trial, people on the highest dose lost an average of around 11.2% of their body weight over 72 weeks.
It isn't available on the NHS yet, but can be purchased after a private consultation.
The GLP-1 field moves fast. Before we knew it, obesity could be managed with GLP-1 injections. And now, every once in a while, we’re at the edge of another revolution in the field: A GLP-1 oral pill.
First, there was the Wegovy pill by Novo Nordisk, which was approved by the MHRA in June 2026. In just two more months, we now have another GLP-1 pill by Eli Lilly, called orforglipron, or Foundayo.
On 10 August, 2026, the MHRA approved the orforglipron oral pill manufactured by Eli Lilly, naming it Foundayo, for managing obesity and type 2 diabetes. A couple of weeks later, Foundayo was available at private clinics and pharmacies, including OnlineClinic.
This guide outlines all you need to know about Foundayo, the newest weight loss pill in the UK, and what it means for your weight loss journey, your health trajectory, and all the weight management options that existed before.
Also, explore how it works, its weight loss results, side effects, eligibility, and more.
Before you begin: A little bit about OnlineClinic
OnlineClinic has been operating since 2011 and has treated more than 2.1 million patients.
The pharmacy is registered with the General Pharmaceutical Council (GPhC), our prescribers are registered with the General Medical Council (GMC), and the service is regulated by the Care Quality Commission (CQC).
As of September 2026, on Trustpilot, the service rating is 4.6 out of 5 based on 6,832 reviews.
Foundayo is Eli Lilly's brand name for a medicine called orforglipron.
It works on the same GLP-1 hormone pathway as Mounjaro and Wegovy, reducing appetite and helping you feel full sooner. That part will sound familiar.
Where it differs is in the details, and the details matter here.
It's a tablet, not an injection. Mounjaro and Wegovy are both weekly injections. Foundayo is a pill you take once a day. For anyone who's been put off GLP-1 treatment by needle anxiety, or who's simply never liked the idea of injecting themselves, this is a life-changing invention.
It only targets one hormone pathway, not two. Mounjaro works on two hormones, GLP-1 and GIP, which is why it tends to produce the highest average weight loss compared to currently available options. Foundayo, however, works on GLP-1 alone, which is why Mounjaro and Foundayo aren't expected to produce identical results.
It's genuinely new as a type of medicine. Foundayo is the first tablet of its kind, a small molecule that doesn't need to be built the same way as older GLP-1 medicines. This medicine allows you to skip the food and water restrictions that come with the Wegovy pill.
Quick tip
If someone mentions "the Wegovy pill," they mean a different medicine, oral semaglutide, made by Novo Nordisk. Foundayo is a Lilly product and works a little differently. We've written a separate guide to the Wegovy pill if that's the one you're after.
| Foundayo | Mounjaro | Wegovy | Wegovy pill | |
|---|---|---|---|---|
| Form | Pill | Weekly injection | Weekly injection | Pill |
| Active ingredient | Orforglipron | Tirzepatide | Semaglutide | Semaglutide |
| Hormone target | GLP-1 only | GLP-1 and GIP | GLP-1 only | GLP-1 only |
| Manufacturer | Eli Lilly | Eli Lilly | Novo Nordisk | Novo Nordisk |
| Food or water rules | Not applicable | Not applicable | Not applicable | The pill needs to be taken on an empty stomach after an 8-hour fast and once it’s taken, wait for 30 minutes before eating or drinking anything |
| Average weight loss | ~11.2% at 72 weeks (ATTAIN-1) | ~20.9% at 72 weeks (SURMOUNT-1) | ~14.9% at 68 weeks (STEP 1) | ~14% weight loss at 64 weeks (OASIS-4) |
| UK regulatory status | MHRA authorised | MHRA licensed | MHRA licensed | MHRA licensed |
| NHS recommended | NICE guidance not yet published | NICE-recommended (TA1026) | NICE-recommended (TA875) | NICE guidance not yet published |
| Cold-chain storage needed | No (Store at room temperature between 20°C to 25°C) | Yes | Yes | No |
Trial results are from separate studies with different populations and durations, so treat this as a general guide rather than a head-to-head comparison. Full sources are listed at the end of this article.
To understand how Foundayo works, you need to understand a few basics first: GLP-1 is a hormone your gut already makes naturally, after you eat, to tell your brain you've had enough and to slow down digestion a little.
GLP-1 medications are designed to mimic that signal more strongly and for longer.
Foundayo does this in the form of a pill rather than an injection, which sounds like a small technical difference, but is actually the tricky bit scientists have been trying to solve for years.
Most hormone-mimicking drugs are proteins, and proteins get broken down by stomach acid before they can do anything useful, which is exactly why Mounjaro and Wegovy have to be injected in the first place.
Foundayo gets around this by being built differently, as what's called a small molecule rather than a protein.
Practically, that means it survives your digestive system intact, gets absorbed, and does its job, all without needing an injection or the special coating that the Wegovy pill relies on.
While the Wegovy pill has to be taken first thing in the morning, on an empty stomach, with a small sip of water, waiting for another half an hour before eating, drinking anything else, or taking other medicines, Foundayo is easier to take.
Here is how to take Foundayo the right way:
Foundayo is introduced gradually, in six steps, starting from 0.8mg and going upto 17.2mg. The dose increases at least once a month as your body adjusts.
| Stage | Dose | Minimum time at this step | What this dose is for |
|---|---|---|---|
| 1 | 0.8mg once daily | 4 weeks | Introduction. Lets your body adjust to orforglipron. Not expected to produce much weight loss on its own. |
| 2 | 2.5mg once daily | At least 4 weeks | Early therapeutic dose. |
| 3 | 5.5mg once daily | At least 4 weeks | Common early maintenance dose. |
| 4 | 9mg once daily | At least 4 weeks | Common maintenance dose for many people. |
| 5 | 14.5mg once daily | At least 4 weeks | Higher dose, used when more weight loss is needed, and lower doses are well tolerated. |
| 6 | 17.2mg once daily | Maintenance | Maximum dose. The dose used by the highest-performing group in the ATTAIN-1 trial. |
This step-by-step approach is standard across GLP-1 medications and is one of the main ways side effects are kept manageable.
To know more about Mounjaro and Wegovy’s dosage schedule, you can read on guides on Mounjaro dosage schedule and Wegovy dosage schedule.
For Foundayo (orforglipron), a 72-week clinical trial took place, with 3,127 participants involved. Here’s what the trial showed.
ATTAIN -1 trial results for Foundayo (Orforglipron)
Published in the New England Journal of Medicine, September 2025.
Average weight loss by dose at 72 weeks:
Quick tip
In the same trial, around 55% of participants on the highest dose lost at least 10% of their body weight, and around 36% of participants lost 15% or more of their body weight.
If you've read anything about Mounjaro or Wegovy already, none of this will come as a surprise.
Foundayo belongs to the same family of medicines, and the side-effect pattern reflects that.
The side effects reported most often in the trial were:
Here's the good part
No signal of liver problems showed up across the Foundayo trials, something researchers watch closely with any new medicine in a pill form.
To get a better picture of side effects caused by Mounjaro and Wegovy along with how to manage them, you can refer to our guides on Mounjaro side effects and Wegovy side effects.
Foundayo is intended for adults who meet the standard UK eligibility criteria for weight loss medication, and who are looking for a pill rather than a weekly injection.
To be eligible for Foundayo, you'll generally need:
A prescriber will also want to understand your full medical history, your current medications, and what has led you to consider treatment now before agreeing that Foundayo is the right fit.
Beyond the formal criteria, Foundayo tends to suit people who:
Mounjaro currently has the strongest trial results of the four options.
Foundayo's strength is convenience, not a bigger number on the scale.
Foundayo is not suitable for anyone under 18.
As with all GLP-1 medications, treatment is for adults only.
Foundayo isn't suitable for everyone, and a prescriber will always check your full medical history before agreeing to it. You shouldn't take it if you:
You'll need a proper conversation with a prescriber if you have a history of pancreatitis or gallbladder problems, severe kidney or liver issues, an eating disorder, or if you're already taking insulin or other diabetes medication.
Not currently. Foundayo is a private-prescription-only medicine in the UK right now.
The National Institute for Health and Care Excellence (NICE) is separately reviewing whether Foundayo should be recommended for weight management.
Whatever that guidance says, it won't change anything overnight. It's simply the next step in a longer regulatory process.
For now, if you want to explore whether Foundayo could be right for you, you can opt for a private consultation at OnlineClinic.
Whenever a new weight-loss medicine makes headlines, counterfeit versions tend to follow within weeks. The MHRA has already seized a significant number of fake GLP-1 products over the past year, and pharmacists have specifically flagged the risk of counterfeit Foundayo appearing online given how much attention the launch has attracted.
Stay safe
A few things worth knowing:
At OnlineClinic, Foundayo prices start from £87.99 onwards.
The price is inclusive of next-day delivery and prescription.
Our process is straightforward. From start to finish, this is what happens when you order with us:
Disclaimer
Foundayo (orforglipron) is a prescription-only medicine. It is licensed in the UK for weight management and type 2 diabetes, subject to individual eligibility. Decisions about whether it is suitable for you are made by a GMC-registered prescriber based on your individual medical history. The information here is for general guidance and is not a substitute for professional medical advice.
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Not sure which treatment is right for you?
No obligation · Reviewed by GMC-registered prescribers · CQC regulated